Novonesis AS

Board/Management Information • Nov 28, 2007

TRADING BY MANAGEMENT IN NOVOZYMES A/S B SHARES

November 28, 2007

In accordance with Section 28a of the Danish Securities Trading Act, Novozymes reports the following transactions under ISIN DK0010272129, Novozymes B shares under the symbol NZYM B.

Name	Relation/ Category of close relation	Trading date	Character of the transaction	No. of shares trader Buy (+) / (Sell (-) No.)	Market value of shares traded (DKK)
Per Falholt	EVP, Research & Development	28/11 2007	Shares	- 3,000	1,620,000

Contact persons:

Annegrethe M. Jakobsen Tel. (direct): +45 4446 3050 Tel. (mobile): +45 3077 3050

Johan Melchior Tel. (direct): +45 4446 0690 Tel. (mobile): +45 3077 0690

Media Relations: Investor Relations:

Camilla Kinch Jensen Phone (direct): +45 4446 0852 Phone (mobile): +45 3077 0852

Ian Christensen Phone (direct): +45 4446 0341 Phone (mobile): +45 3077 0341

Tobias Bjørklund (North America) Phone (direct): +1 919 494 3483 Phone (mobile): +1 919 649 2565

Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources. Read more at www.novozymes.com.

Stock exchange announcement no. 31, 2007 Page 1 of 1 Novozymes A/S Investor Relations Krogshøjvej 36 2880 Bagsværd Denmark

Telephone: +45 4446 0000 Fax: +45 4446 1002

Internet: www.novozymes.com CVR number: 10 00 71 27